acetyl cedrene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 107065 |
SCHEMBL ID | 442537 |
MeSH ID | M0243501 |
Synonym |
---|
vertofix coeur |
acetyl cedrene |
68039-35-0 |
1-(2,3,4,7,8,8a-hexahydro-3,6,8,8-tetramethyl-1h-3a,7-methanoazulen-5-yl)ethan-1-one |
ethanone, 1-(2,3,4,7,8,8a-hexahydro-3,6,8,8-tetramethyl-1h-3a,7-methanoazulen-5-yl)- |
9-acetyl-2,6,6,8-tetramethyltricyclo(5.3.1.01,5)undec-8-ene |
einecs 268-253-1 |
2,3,4,7,8,8a-hexahydro-3,6,8,8-tetramethyl-5-acetyl-1h-3a,7-methanoazulene |
FT-0628713 |
acetyl-.alpha.-cedrene |
AKOS015899802 |
SCHEMBL442537 |
1h-3a,7-methanoazulene, ethanone deriv. |
DTXSID00860469 |
1-(2,3,4,7,8,8a-hexahydro-3,6,8,8-tetramethyl-1h-3a,7-methanoazulen-5-yl)-ethanone |
1-(2,6,6,8-tetramethyl-9-tricyclo[5.3.1.01,5]undec-8-enyl)ethanone |
Acetyl cedrene is a member of the fragrance structural group Alkyl Cyclic Ketones.
Excerpt | Reference | Relevance |
---|---|---|
"Acetyl cedrene is a member of the fragrance structural group Alkyl Cyclic Ketones." | ( Fragrance material review on acetyl cedrene. Api, AM; Letizia, CS; Politano, VT; Scognamiglio, J, 2013) | 1.4 |
Excerpt | Relevance | Reference |
---|---|---|
" First and last day dosing suspensions were analyzed for AC content." | ( Evaluation of the developmental toxicity of acetyl cedrene. Api, AM; Christian, MS; Diener, RM; Isola, DA; Lapczynski, A, ) | 0.39 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (41.09) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (20.00%) | 6.00% |
Case Studies | 1 (20.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 3 (60.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |